HealthQuill Boston US
Novartis AG, one of the world’s top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion to expand its cardiovascular pipeline.
Uncategorized

Switzerland’s Novartis to buy US-based Anthos for $3.1 billion

Novartis AG, one of the world’s top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion.

Read More
Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six years and older, according to a statement from the company.
Drugs Health Medical Research

Vertex gets US regulator’s nod for extended use of cystic fibrosis drug

Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six.

Read More